Semaglutide primarily mimics the GLP-1 hormone, focusing on appetite suppression
Modern advances in long-acting peptide design, biased agonism, receptor de-orphanization, and systems pharmacology fundamentally alter the riskbenefit calculus of these targets
So far, though, such clinical trials have yielded inconsistent results
Proteotoxic stress A cellular condition caused by the accumulation of misfolded, aggregated or damaged proteins, overwhelming the protein quality control systems and disrupting normal cellular function
While semaglutide works by mimicking a natural hormone (GLP-1) that slows digestion and reduces appetite, tirzepatide goes a step further by targeting both GLP-1 and GIP receptors , offering even more powerful appetite control and metabolic support